Oncolytics Biotech
ONCY
$1.18
Share price
1.72%
Change (1 day)
-30.99%
Change (1 year)
Categories
Number of shares outstanding for Oncolytics Biotech (ONCY)
Number of shares outstanding as of May 2024 : 69,803,255
According to Oncolytics Biotech 's latest financial reports and stock price the company's current number of shares outstanding is 69,803,255. At the end of 2023 the company had 69,803,255 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Oncolytics Biotech from 2018 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 69.8 M | 19.68% |
| 2022 | 58.32 M | 6.12% |
| 2021 | 54.96 M | 31.74% |
| 2020 | 41.72 M | 84.26% |
| 2019 | 22.64 M | 36.89% |
| 2018 | 16.54 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Eli Lilly LLY | 949,379,000 | 1,260.08% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 2,023,000,000 | 2,798.15% | 🇺🇸 USA |
 Mirati Therapeutics MRTX | 64,993,079 | -6.89% | 🇺🇸 USA |
 Aeterna Zentaris AEZS | 4,857,759 | -93.04% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | 1,121,000,000 | 1,505.94% | 🇮🇱 Israel |
 AVEO Oncology
AVEO | 34,618,000 | -50.41% | 🇺🇸 USA |